I followed a University of Alberta cancer research protocol about 14 years ago that was promising, and then once it moved to a pharmaceutical firm for final testing and getting the product to market, the solution changed course and was only being used as a diagnostic tool. I was only following as an interested observer, and couldn't get my mind around how frustrating that must have been for the researchers.
I assure you I'm not trying to get all conspiracy theory-ee.
If the research lab gets the required funding, goes to human trials, is there a way to move forward beyond that without the involvement of an American pharmaceutical company? Seriously asking, for anyone who might have an answer.
__________________
"By Grabthar's hammer ... what a savings."
|